Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 May;75(5):973-9.
doi: 10.1016/j.gie.2011.12.014. Epub 2012 Feb 15.

Evaluation of GI bleeding after implantation of left ventricular assist device

Vladimir M Kushnir  1 , Shivak Sharma, Gregory A Ewald, Jonathan Seccombe, Eric Novak, I-Wen Wang, Susan M Joseph, C Prakash Gyawali
Affiliations

Evaluation of GI bleeding after implantation of left ventricular assist device

Vladimir M Kushnir et al. Gastrointest Endosc. 2012 May.

Abstract

Background: Left ventricular assist devices (LVADs) have revolutionized the management of end-stage heart failure (ESHF). However, unexpectedly high rates of GI bleeding (GIB) have been described, and etiology and outcome remain unclear.

Objective: To determine the prevalence, etiology, and outcome of GIB in LVAD recipients.

Design: Retrospective case series.

Setting: Tertiary care academic university hospital.

Patients: 154 ESHF patients (55.4 years, 122 men/32 women) with LVADs implanted over a 10-year period.

Main outcome measurements: Overt or occult GIB prompting endoscopic evaluation ≥ 7 days after LVAD implantation.

Results: Over a mean of 0.9 ± 0.1 years of follow-up, 29 patients (19%) experienced 44 GIB episodes. Patients with GIB were older and received anticoagulation therapy before devices were implanted (P ≤ .02 for each). GIB was overt (n = 31) rather than occult (n = 13), and most patients presented with melena (n = 22, 50%); hemodynamic instability was observed in 13.6%. Each bleeding episode required 2.1 ± 0.1 diagnostic or therapeutic procedures, and a source was localized in 71%. Upper endoscopy provided the highest diagnostic yield; peptic bleeding (n = 14) and vascular malformations (n = 8) dominated the findings. Endoscopy was safe and well tolerated. Overall mortality was 35%, none directly from GIB.

Limitation: Retrospective design.

Conclusions: Rates of GIB with LVADs are higher than that seen in other patient populations, including those receiving anticoagulation and antiplatelet therapy. GIB episodes are mostly overt and predominantly from the upper GI tract. Endoscopy is safe in the LVAD population.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Diagnostic yield of endoscopic and radiologic procedures performed for the evaluation of gastrointestinal bleeding in patients with LVADs. Upper endoscopy had the highest yield for a source of bleeding, significantly higher than that seen with colonoscopy or enteroscopy. The number of capsule endoscopy (5) and radiologic procedures (8) performed were limited. (*p<0.05 compared to colonoscopy and enteroscopy)
See this image and copyright information in PMC

References

    1. McMurray JJ. Clinical practice. Systolic heart failure. N Engl J Med. 2010;362(3):228–238. - PubMed
    1. Johnson MR, Meyer KH, Haft J, Kinder D, Webber SA, Dyke DB. Heart transplantation in the United States, 1999–2008. Am J Transplant. 2010;10(4 Pt 2):1035–1046. - PubMed
    1. Rose EA, Gelijns AC, Moskowitz AJ, Heitjan DF, Stevenson LW, Dembitsky W, et al. Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med. 2001;345(20):1435–1443. - PubMed
    1. Miller LW, Pagani FD, Russell SD, John R, Boyle AJ, Aaronson KD, et al. Use of a continuous-flow device in patients awaiting heart transplantation. N Engl J Med. 2007;357(9):885–896. - PubMed
    1. Slaughter MS, Rogers JG, Milano CA, Russell SD, Conte JV, Feldman D, et al. Advanced heart failure treated with continuous-flow left ventricular assist device. N Engl J Med. 2009;361(23):2241–2251. - PubMed

MeSH terms